Caitlin O'Mahony Hartnett currently serves as a Senior Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson, where she plays a pivotal role in advancing the development of innovative digital technologies within the realm of monoclonal antibody therapeutics. With a robust background in protein...
Caitlin O'Mahony Hartnett currently serves as a Senior Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson, where she plays a pivotal role in advancing the development of innovative digital technologies within the realm of monoclonal antibody therapeutics. With a robust background in protein therapeutics API development, Caitlin is at the forefront of optimizing manufacturing processes to enhance efficiency and product quality. Her leadership of the Advanced Process Control BTDS group underscores her expertise in integrating cutting-edge process analytical technologies, such as Raman spectroscopy and multivariate analysis (MVA) modeling, into drug substance production.
Caitlin's work is instrumental in transforming traditional manufacturing paradigms by leveraging data-driven insights to refine and streamline workflows. This not only accelerates the development timeline for new therapeutics but also ensures compliance with stringent regulatory standards. Her proficiency in genetics, cell culture, and immunology, combined with her hands-on experience in techniques such as ELISA, RT-PCR, and fluorescence microscopy, allows her to bridge the gap between laboratory research and scalable production.
Key projects led by Caitlin include the implementation of advanced analytical frameworks that enhance real-time monitoring and control of bioprocesses, ultimately driving improvements in yield and consistency. As a thought leader in the field, she actively contributes to cross-functional teams, fostering collaboration that fuels innovation and supports the mission of delivering life-changing therapies to patients. Through her dedication and expertise, Caitlin O'Mahony Hartnett exemplifies the commitment to excellence that defines The Janssen Pharmaceutical Companies.
